During the past decade, Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle" are "Systemic Mastocytosis" (2 trials), "Advanced Systemic Mastocytosis" (1 trials), "Aggressive Systemic Mastocytosis" (1 trials), "Indolent Systemic Mastocytosis" (1 trials) and "Mast Cell Leukemia" (1 trials). Many other conditions were trialed in "Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle" in a lesser frequency.

Most popular intervention types in "Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Avapritinib" (2 trials), "Cladribine and pegylated interpheron alpha-2a" (1 trials), "Imatinib Mesylate" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".